Cargando…

Cholesterol-Induced Non-Alcoholic Fatty Liver Disease and Atherosclerosis Aggravated by Systemic Inflammation

Although triglyceride accumulation in the liver causes non-alcoholic fatty liver disease (NAFLD), hypercholesterolemia is also a main cause of NAFLD as well as atherosclerosis. However, NAFLD and atherosclerosis have not been investigated simultaneously in animal models fed a high-cholesterol diet....

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Eung Ju, Kim, Baek-hui, Seo, Hong Seog, Lee, Yong Jik, Kim, Hyun Hee, Son, Hyun-Hwa, Choi, Man Ho
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4046981/ https://www.ncbi.nlm.nih.gov/pubmed/24901254 http://dx.doi.org/10.1371/journal.pone.0097841

Ejemplares similares

High-temperature GC-MS-based serum cholesterol signatures may reveal sex differences in vasospastic angina
por: Son, Hyun-Hwa, et al.
Publicado: (2014)

Aspirin Improves Nonalcoholic Fatty Liver Disease and Atherosclerosis through Regulation of the PPARδ-AMPK-PGC-1α Pathway in Dyslipidemic Conditions
por: Han, Yoon-Mi, et al.
Publicado: (2020)

Significance of Triglyceride-to-High-Density Lipoprotein Cholesterol Ratio in Children with Non-Alcoholic Fatty Liver Disease
por: Kim, Hyun Jin
Publicado: (2023)

Characterization of glucose uptake metabolism in visceral fat by (18 )F-FDG PET/CT reflects inflammatory status in metabolic syndrome
por: Pahk, Kisoo, et al.
Publicado: (2020)

Thyrotropin aggravates atherosclerosis by promoting macrophage inflammation in plaques
por: Yang, Chongbo, et al.
Publicado: (2019)

Early-stage non-alcoholic fatty liver disease in relation to atherosclerosis and inflammation
por: Tan, Si-hua, et al.
Publicado: (2023)

Fimasartan Ameliorates Nonalcoholic Fatty Liver Disease through PPARδ Regulation in Hyperlipidemic and Hypertensive Conditions
por: Lee, Yong-Jik, et al.
Publicado: (2017)

MRI of atherosclerosis and fatty liver disease in cholesterol fed rabbits
por: Taylor, Erik, et al.
Publicado: (2018)

Cholesterol efflux pathways, inflammation, and atherosclerosis
por: Groenen, Anouk G., et al.
Publicado: (2021)

Impaired HDL cholesterol efflux capacity in patients with non-alcoholic fatty liver disease is associated with subclinical atherosclerosis
por: Fadaei, Reza, et al.
Publicado: (2018)

Correction: Thyrotropin aggravates atherosclerosis by promoting macrophage inflammation in plaques
por: Yang, Chongbo, et al.
Publicado: (2022)

Fatty Exosomes Aggravate Metabolic Disorders
por: Jung, Young Hyun, et al.
Publicado: (2022)

Prevalence of Non-Alcoholic Fatty Liver Disease (NAFLD) in Korean Patients Undergoing Bariatric Surgery
por: Kim, Ki Hyun, et al.
Publicado: (2022)

Caffeoylquinic Acid-Rich Extract of Aster glehni F. Schmidt Ameliorates Nonalcoholic Fatty Liver through the Regulation of PPARδ and Adiponectin in ApoE KO Mice
por: Lee, Yong-Jik, et al.
Publicado: (2017)

Oxaliplatin aggravates hepatic oxidative stress, inflammation and fibrosis in a non-alcoholic fatty liver disease mouse model
por: Lu, Yulei, et al.
Publicado: (2019)

Corrigendum to “Caffeoylquinic Acid-Rich Extract of Aster glehni F. Schmidt Ameliorates Nonalcoholic Fatty Liver through the Regulation of PPARδ and Adiponectin in ApoE KO Mice”
por: Lee, Yong-Jik, et al.
Publicado: (2019)

Cholesterol and Inflammation in Atherosclerosis: An Immune-Metabolic Hypothesis
por: Mauricio, Didac, et al.
Publicado: (2020)

Implication of Nonalcoholic Fatty Liver Disease, Metabolic Syndrome, and Subclinical Inflammation on Mild Renal Insufficiency
por: Nam, Ga Eun, et al.
Publicado: (2018)

Hypoxanthine induces cholesterol accumulation and incites atherosclerosis in apolipoprotein E‐deficient mice and cells
por: Ryu, Hye‐Myung, et al.
Publicado: (2016)

Barley Sprouts Extract Attenuates Alcoholic Fatty Liver Injury in Mice by Reducing Inflammatory Response
por: Lee, Yun-Hee, et al.
Publicado: (2016)

Mean and visit‐to‐visit variability of glycated hemoglobin, and the risk of non‐alcoholic fatty liver disease
por: Yoo, Jee Hee, et al.
Publicado: (2020)

Gender-based differences in the relationship between fatty liver disease and atherosclerosis
por: Kim, Hyun-Jin, et al.
Publicado: (2016)

Targeting Liver X Receptors for the Treatment of Non-Alcoholic Fatty Liver Disease
por: Kim, Hyejin, et al.
Publicado: (2023)

Immune Checkpoint Inhibitor Therapy Aggravates T Cell–Driven Plaque Inflammation in Atherosclerosis
por: Poels, Kikkie, et al.
Publicado: (2020)

Dietary advanced glycation end-products aggravate non-alcoholic fatty liver disease
por: Leung, Christopher, et al.
Publicado: (2016)

Disturbances in Cholesterol Homeostasis and Non-alcoholic Fatty Liver Diseases
por: Malhotra, Pooja, et al.
Publicado: (2020)

Acute exposure to silica nanoparticles aggravate airway inflammation: different effects according to surface characteristics
por: Park, Hye Jung, et al.
Publicado: (2015)

Auranofin Attenuates Non-Alcoholic Fatty Liver Disease by Suppressing Lipid Accumulation and NLRP3 Inflammasome-Mediated Hepatic Inflammation In Vivo and In Vitro
por: Hwangbo, Hyun, et al.
Publicado: (2020)

Roles of Achieved Levels of Low-Density Lipoprotein Cholesterol and High-Sensitivity C-Reactive Protein on Cardiovascular Outcome in Statin Therapy
por: Hyun, Myung Han, et al.
Publicado: (2019)

Nonalcoholic Fatty Liver Disease for Identification of Preclinical Carotid Atherosclerosis
por: Sinn, Dong Hyun, et al.
Publicado: (2016)

Does Rapid Eye Movement Sleep Aggravate Obstructive Sleep Apnea?
por: Kim, Sung Hee, et al.
Publicado: (2019)

Multiparametric MR Index for the Diagnosis of Non-Alcoholic Steatohepatitis in Patients with Non-Alcoholic Fatty Liver Disease
por: Kim, Jeong Woo, et al.
Publicado: (2020)

Pharmacological systemic analysis of gardenia fructus against non-alcoholic fatty liver disease and validation of animal models
por: Lee, Kang Pa, et al.
Publicado: (2022)

Endothelial dysfunction and carotid atherosclerosis in non-alcoholic fatty liver disease
por: Dogru, Teoman, et al.
Publicado: (2014)

Atherosclerosis, Inflammation, and Genetics - And you Thought it Was Just LDL-cholesterol
por: Gowdak, Luis Henrique Wolff
Publicado: (2020)

Optimal LDL cholesterol levels in young and old patients with type 2 diabetes for secondary prevention of cardiovascular diseases are different
por: Jeong, Chaiho, et al.
Publicado: (2023)

Effect of Exercise on Inflamed Psoas Muscle in Women with Obesity: A Pilot Prospective (18)F-FDG PET/CT Study
por: Pahk, Kisoo, et al.
Publicado: (2021)

Association of Inflammatory Metabolic Activity of Psoas Muscle and Acute Myocardial Infarction: A Preliminary Observational Study with (18)F-FDG PET/CT
por: Pahk, Kisoo, et al.
Publicado: (2021)

Sex-specific metabolic interactions between liver and adipose tissue in MCD diet-induced non-alcoholic fatty liver disease
por: Lee, Yun-Hee, et al.
Publicado: (2016)

Hepatokines and Non-Alcoholic Fatty Liver Disease: Linking Liver Pathophysiology to Metabolism
por: Kim, Tae Hyun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rtdsrdv7rtgqlrjrpvnrh9tb2g